top of page

JOB PUBLICATIONS

A. PUBLICATIONS OF COMPLETE WORKS IN INTERNATIONAL

PERIODICALLY

 

1. Results on the treatment of uterine cervix cancer: ten years experience.

Papanikolaou A, Kalogiannidis I, Misailidou D, Goutzioulis M, Stamatopoulos P, Makedos A, Vatopoulou A, Makedos G.

Eur J Gynaecol Oncol. 2006;27(6):607-10.

 

2. Homocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsia.

Makedos G, Papanicolaou A, Hitoglou A, Kalogiannidis I, Makedos A, Vrazioti V, Goutzioulis M.

Arch Gynecol Obstet. 2007 Feb;275(2):121-4. Epub 2006 Aug 29.

 

3. Pelvic lymphadenectomy as an alternative to postoperative

radiotherapy in high risk early stage endometrial cancer.

Papanikolaou A, Kalogiannidis I, Goutzioulis M, Misailidou D, Makedos A, Vergote I, Makedos G.

Arch Gynecol Obstet. 2006 May;274(2):91-6. Epub 2006 Mar 4.

 

4. Immunohistochemical bcl-2 expression, p53 overexpression, PR and ER status in endometrial carcinoma and survival outcomes.

Kalogiannidis I, Bobos M, Papanikolaou A, Makedos A, Amplianitis I, Vergote I, Nenopoulou E, Makedos G.

Eur J Gynaecol Oncol. 2007;29(1):19-25.

 

5. Clear cell ovarian carcinoma following polymyositis diagnosis: a case report and review.

I. Kalogiannidis, A. Papanikolaou, I. Xanthakis, A. Makedos, N. Prapas.

Hippokratia. 2008 Jul;12(3):181-5.

 

6. Operative vaginal delivery in singleton term pregnancies: Short-term maternal and neonatal outcomes.

Prapas N, Kalogiannidis I, Masoura S, Diamanti E, Makedos A, Drossou D, Makedos G.

Hippokratia. 2009 Jan;13(1):41-5.

 

7. Serum C-reactive protein and homocysteine changes during hormonal therapy in women with polycystic ovary syndrome: a prospective, control-matched study.

Makedos A, Goulis D, Papanikolaou A, Panidis D.

Angiology. 2010 Aug;61(6):595-601.

 

8. Increased serum C-reactive protein levels in normal weight women with polycystic ovary syndrome.

Makedos A1, Goulis D G2, Arvanitidou M3, Mintziori G2, Papanikolaou A2, Makedou A1, Panidis D1 

Hippokratia, 15(4), 2011.

 

9. Meta-analysis of cardiovascular disease risk markers in women with polycystic ovary syndrome.

 

Toulis KA, Goulis DG, Mintziori G, Kintiraki E, Eukarpidis E, Mouratoglou SA, Pavlaki A, Stergianos S, Poulasouchidou M, Tzellos TG, Makedos A, Chourdakis M, Tarlatzis BC.

Hum Reprod Update. 2011 Nov-Dec;17(6):741-60. 

 

10. Diagnosis of peritoneal tuberculosis: random involvement of gynecologists.

Makedos A, Mandala E, Ilonidis G, Makedos G.

Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):482. No abstract available.

 

11. Symptomatic subserous multicystic uterus: Case report.

Pados G, Makedos A, Diamanti K, Ntinou Z, Zaramboukas T, Tarlatzis B.

JMIG. Accepted for publication November 2012. No abstract available.

 

12. Effect of short-term tibolone treatment on risk markers for cardiovascular disease in healthy postmenopausal women: A randomized-controlled study.

A. Traianos, D. Vavilis, A. Makedos, A. Karkanaki, K. Ravanos, N. Prapas, BC Tarlatzis.

Clinical and Experimental Obstetrics and Gynecology. Accepted for publication December 2012.

 

13. Uterine manifestations of tuberous sclerosis complex as a random finding at laparoscopy.

Pados G, Makedos A, Tsolakidis D, Tarlatzis B.

Int J Gynecol Obstet. 2013 Aug;122(2):156-7.

 

14. Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.

 

Kolibianakis EM, Venetis CA, Bosdou JK, Zepiridis L, Chatzimeletiou K, Makedos A, Masouridou S, Triantafillidis S, Mitsoli A, Tarlatzis BC

Hum Reprod. 2014 Dec 9. pii: deu301. [Epub ahead of print]

 

15. Is the time interval between HCG administration and oocyte retrieval associated with oocyte retrieval rate?

 

Bosdou JKKolibianakis EMVenetis CAZepiridis LChatzimeletiou KMakedos ATriantafyllidis SMasouridou SMitsoli ATarlatzis B.

Reprod Biomed Online. 2015 Aug 13. pii: S1472-6483(15)00383-1. doi: 10.1016/j.rbmo.2015.08.005. [Epub ahead of print]

 

16. Transdermal testosterone pretreatment in poor responders undergoing ICSI: a randomized clinical trial.

 

Bosdou JKVenetis CADafopoulos KZepiridis LChatzimeletiou KAnifandis GMitsoli AMakedos AMessines IETarlatzis BCKolibianakis EM.

Hum Reprod. 2016 May;31(5):977-85.

17.  Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women.

Pados George, Tsolakidis Dimitrios, Theodoulidis Dimitris, Makedos Anastasios, Zarboukas Thomas, Tarlatzis Basil

Human Reproduction 2017 Oct 1;32(10):2036-2041

18.  Classification and diagnosis of congenital malformations of the female genital
tract according to ESHRE/ESGE 

Anastasios Makedos, Grigoris Grimbizis

HJOG 2018, 17 (3), 53-60

19. Addition of procyanidin to semen preserves progressive sperm motility up to three hours of incubation

H Awaga, S Lymperi, J Bosdou, A Makedos, A Mitsoli, M Bazioti, D Savvaidou, D Goulis, K Chatzimeletiou, M Saleh, S Ahmed, G Grimbizis, B Tarlatzis, E Kolibianakis

Reprod Biol 2019 Sep; 19(3);255-260

20. Expression of genes that regulate follicle development and maturation during ovarian stimulation in poor responders

H Vaitsopoulou, E Kolibianakis, J Bosdou, E Neofytou, S Lymperi, A Makedos, D Savvaidou, K Chatzimeletiou, G Grimbizis, A Lambropoulos, B Tarlatzis

Reprod Biomed Online. 2021 Jan;42(1):248-259.

 

 

B. PUBLICATIONS OF ABSTRACTS IN INTERNATIONAL JOURNALS

 

1. Clinicopathological study of Bcl-2 immunohistochemical expression in endometrioid adenocarcinoma.

Bobos M, Kalogiannidis I, Papanikolaou A, Makedos A, Makedos G,

Nenopoulou E.

 

2. Increased Serum C-Reactive Protein levels in normal weight women with Polycystic Ovary Syndrome.

Makedos A, Booth A, Arnaoutoglou C, Kalogiannidis I, Makedos G, Panidis D.

Transactions of the North of England Obstetrical and Gynaecological

Society, 2006 New Series, Volume 16.

 

3. Changes of serum C-reactive protein (CRP) and homocysteine levels in women with Polycystic Ovary Syndrome (PCOS) during hormonal therapy.

Makedos A, Panidis D, Papanikolaou A, Hitoglou A, Kalogiannidis I,

Asteriadis C, Makedos G.

Human Reproduction, Volume 22, Supplement 1, 2007.

 

4. The role of pentothal for anesthesia during oocyte retrieval is associated with decreased pregnancy rates as compared to propofol: a randomized controlled trial.

E. Goutziomitrou, EM Kolybianakis, CA Venetis, S. Masouridou, A. Makedos, G. Grimbizis, A. Parlapani, K. Chatzimeletiou, A. Mitsoli, TB Tarlatzi, BC Tarlatzis.

Human Reproduction, Volume 26, Supplement 1 2011: Abstract Book.

 

5. Low oxygen embryos culture is associated with improved day 3 embryo quality: a prospective randomized controlled trial.

A. Mitsoli, EM Kolibianakis, K. Loutradi, CA Venetis, S. Triantafilidis, A. Makedos, K. Chatzimeletiou, L. Zepiridis, H. Bili, G. Pados, A. Tzamtzoglou, BC Tarlatzis.

Human Reproduction, Volume 26, Supplement 1 2011: Abstract Book.

 

6. Symptomatic subserous multicystic uterus: case presentation.

Pados G, Makedos A, Diamanti K, Ntinou Z, Misiaka D, Tarlatzis B.

Gynecological Surgery (2011) 8 (Suppl 1):S1-S225.

 

7. Short-term effects of tibolone on risk markers for metabolic syndrome in healthy postmenopausal women.

A. Traianos, D. Vavilis, N. Prapas, A. Karkanaki, A. Makedos, B. Tarlatzis.

Maturitas. Volume 71, Supplement 1 (2012).

 

8. Borderline tumors of the ovary: key hole surgery offers the key for them in time. 

 

G. Pados, S. Masouridou, D. Tsolakidis, A. Makedos, T. Zarampoukas, B. Tarlatzis.

Gynecol Surg (2012) 9 (Suppl 1):S1–S137.

 

9. Uterine manifestations of Bourneville's disease: case report and video presentation.

G. Pados, A. Makedos, D. Tsolakidis, K. Almaloglou, B. Tarlatzis.

Gynecol Surg (2012) 9 (Suppl 1):S1–S137.

 

10. Triggering of final oocyte maturation with GnRH agonist in patients with polycystic ovaries undergoing IVF.

A. Makedos, EM Kolibianakis, CA Venetis, S. Masouridou, K. Chatzimeletiou, L. Zepiridis, A. Mitsoli, G. Lainas, I. Sfontouris, A. Tzamtzoglou, D. Kyrou, T. Lainas, BC Tarlatzis.

Human Reproduction, Volume 28, number S1 June 2013.

 

11. LAPAROSCOPIC REMOVAL OF MISSING SURGICAL SWAB SIX MONTHS AFTER LAPAROTOMY 

 

Makedos Anastasios,  Pados George, Dimitrios Tsolakidis, Almaloglou Konstantinos, Tarlatzis Basil.

Gynecol Surg (2013) 10 (Suppl 1):S1–S151.

 

12. HISTOPATHOLOGIC EVALUATION OF SMOOTH MUSCLE TUMORS REMOVED LAPAROSCOPICLY: OUR EXPERIENCE IN 10 YEARS.

 

Makedos Anastasios, Pados George, Almaloglou Konstantinos, Zaramboukas Thomas, Diamanti Konstantina, Ntinou Zaharoula, Konstadinidis Themistoklis, Tarlatzis Basil.

Gynecol Surg (2013) 10 (Suppl 1):S1–S151.

 

13. THE OBSTETRIC OUTCOME OF PATIENTS WITH UNICORNUATE UTERUS AND NON-COMMUNICATING RUDIMENTARY HORN (ESHRE/ESGE CLASS U4) REMOVED LAPAROSCOPICALLY: A CASE SERIES.

 

G. Pados, E. Koltsida, D. Tsolakidis, A. Makedos, B. Tarlatzis.

Gynecol Surg (2014) 11 (Suppl 1):S1-S358.

 

 

14. EARLY REMOVAL BY LAPAROSCOPY OF MISSING FOREIGN BODIES FROM PREVIOUS OPERATIONS IS THE KEY FOR SUCCESSFUL OUTCOME.

 

G. Pados, A. Makedos, D. Tsolakidis, E. Koltsida, B. Tarlatzis.

Gynecol Surg (2014) 11 (Suppl 1):S1-S358.

 

15. Does extending the time interval between human chorionic gonadotrophin administration and oocyte pick-up by two hours affect oocyte retrieval rate? – a randomized clinical trial

 

JK Bosdou, EM Kolibianakis, CA Venetis, A. Makedos, TB Tarlatzi,

K. Chatzimeletiou, L. Zepiridis, A. Mitsoli, BC Tarlatzis.

Human Reproduction, Volume 29, Supp 1, 2014.

16. Triggering of final oocyte maturation with gonadotrophin releasing hormone agonist in patients with polycystic ovaries undergoing in vitro fertilization.

TB TarlatziEM KolibianakisJK BosdouCA Venetis, A. Makedos, K. ChatzimeletiouL. ZepiridisG. LainasI. SfontourisT. LainasBC Tarlatzis

Fertility and Sterility. 09/2014; 102(3):e262-e263. DOI: 10.1016/j.fertnstert.2014.07.894

17. Transdermal testosterone pre-treatment in poor responders undergoing ICSI: a randomized clinical trial

JK Bosdou1, EM Kolibianakis1, CA Venetis2, K. Dafopoulos3, L.

Zepiridis1, K. Chatzimeletiou1, A. Makedos1, G. Anifandis3, CI Messini3,

A. Daniilidis1, A. Mitsoli1, D. Savvaidou1, IE Messinis3, BC Tarlatzis1

Human Reproduction, Volume 30, Supp 1, 2015.

18. The optimal dose of triptorelin for triggering final oocyte

maturation in patients at high-risk for OHSS: a randomized clinical trial

GT Lainas1, JK Bosdou1, CA Venetis2, IA Sfontouris3, K. Chatzimeletiou1, L. Zepiridis1, A. Makedos1, A. Daniilidis1, A. Mitsoli1,

D. Savvaidou1, TG Lainas3, BC Tarlatzis1, EM Kolibianakis1

Human Reproduction, Volume 30, Supp 1, 2015.

 

19. Blind Secondary Uterine Cavity with Functional Endometrium: an Unclassified Case (U6 C0 V0).

A. Makedos, G. Pados, S. Masouridou, B. Tarlatzis

Gynecol Surg (2015) 12 (Suppl 1): S1–S494

20. GnRH agonist for triggering final oocyte maturation in patients with PCO at high risk for severe OHSS: factors predicting live birth in subsequent FRET cycles.

T. Tarlatzi, J. Bosdou, C. Venetis, G. Lainas, I. Sfontouris, A. Makedos, K. Chatzimeletiou, L. Zepiridis, A. Mitsoli, D. Savaidou, T. Lainas,

B. Tarlatzis, E. Kolibianakis

Human Reproduction, Volume 31, Supp 1 2016

21. Laparoscopic management of an eight centimeter fibroid of the round ligament mimicking pelvic mass of unknown origin.

Anastasios Makedos, George Pados

Gynecol Surg(2016)13(Suppl 1):S1-S453

22. Androgen receptor (AR) mRNA expression is positively associated with live birth in women undergoing in-vitro fertilization independently of the type of ovarian response.

C Vaitsopoulou, E Kolybianakis, E Neofytou, A. Makedos, M Malandri, A Kalpatsanidis, J Bosdou, D Sabbaidou, K Chatzimeletiou, A Lambropoulos, G Grimbizis, B Tarlatzis

Human Reproduction, Vol 33, Supp 1, 2018.

 

 

C. PUBLICATIONS OF FULL PAPER IN GREEK JOURNALS

 

1. Pregnancy after 40. Is it a high risk pregnancy?

E. Drizis, N. Prapas, A. Papanikolaou, A. Makedos, X. Chrysochoidis,

G. Makedos.

GREEK JOURNAL OF GYNECOLOGY & OBSTETRICS vol. 3

issue 3 pp. 239-244, 2004.

 

2. The importance of homocysteine in pregnancy.

A. Papanikolaou, A. Makedos, G. Makedos

GREEK OBSTETRICS & GYNECOLOGY vol. 37(1): 37-42, 2005.

 

3. Comparative study of sikyuulkia and embryoulkia. Effects on maternal and neonatal morbidity.

N. Prapas, I. Kalogiannidis, E. Diamanti, E. Karagiannidou, A. Papanikolaou, A. Makedos, V. Drossou-Agakidou, G. Makedos.

GREEK JOURNAL OF GYNECOLOGY & OBSTETRICS vol. 4

item 1. pp. 59-66, 2005.

 

4. Ovarian hyperstimulation syndrome: complication to disappear.

A. Makedos, G. Gribizis.

Cyprus Medical News. Issue 42, pp. 12-13.

Review of the latest literature.

 

                   D. PUBLICATIONS OF ABSTRACTS IN GREEK JOURNALS

 

1. Prognostic value of ultrasound examination of the fetal urinary system.

Karkanaki A, Kalogiannidis I, Prapas N, Traianos B, Makedos A.

Scientific Journal of the Department of Medicine, Volume 32, Issue 3, 2005.

 

 

2. Ovarian hyperstimulation syndrome.

Karkanaki A, Kalogiannidis I, Prapas N, Traianos B, Makedos A.

Scientific Journal of the Department of Medicine, Volume 32, Issue 3, 2005.

 

 

3. Perinatal morbidity and complications during pregnancy and childbirth in women over 35 years of age.

Masoura S, Kalogiannidis C, Prapas N, Makedos A, Gutzioulis M,

Kyriakidis T, Kurtis A, Makedos G.

Aristotle University Medical Journal, Volume 34, Supplement, May

2007.

 

4. Comparative study of syquulcia-fetus: maternal and neonatal morbidity (7/year retrospective).

Kalogiannidis I, Masoura S, Prapas N, Makedos A, Gutzioulis M,

Psikakos G, Traianos A, Makedos G.

Aristotle University Medical Journal, Volume 34, Supplement, May

2007.

 

5. PTEN expression and survival in patients with endometrial cancer.

Kalogiannidis I, Bobos M, Papanikolaou A, Makedos A, Nenopoulou E.

Archives of Hellenic Pathology, Volume 21, Supplement, 2007.

 

 

6. Comparative study of Homocysteine, Vitamin B12 and folic acid levels in children with and without a family history of cardiovascular disease.

Makedou K, Papageorgiou C, Kurtis A, Makedos A, Boufidou A,

Hitoglou A.

Hellenic Medicine, Volume 73, Supplementary Issue, 2007.

 

7. Retrospective study of perinatal morbidity of premature newborns.

Kalogiannidis I, Margioula-Siarmou X, Petousis S, Daglis T, Makedos A, Karkanaki A, Prapas N, Makedos G.

Perinatal Medicine and Neonatology. Volume 4, Issue 3, July-September 2009.

 

8. The change of the maternal weight during pregnancy in relation to the nationality, the too and the leaf of the fetus.

Poulios X, Theodoulidis B, Daglis T, Masouridou N, Makedos A, Kurtis A, Kalogiannidis I, Prapas N, Makedos G.

Aristotle University Medical Journal, Volume 36, Supplement, April

2009.

 

9. The change in hemoglobin levels before and after childbirth.

Margioula-Siarkou H, Petousis S, Daglis T, Makedos A, Kalogiannidis I, Kurtis A, Prapas N, Makedos G.

Aristotle University Medical Journal, Volume 36, Supplement, April

2007.

 

10. C-reactive protein and γ-glutamate transferase levels in childhood obesity.

K. Makedou, A. Zorba, A. Makedos, E. Moschous, A. Kurtis, A. Makedou.

Greek Atherosclerosis Review, Volume 1, No1, September-December 2010.

 

11. The role of transdermal testosterone before ovarian stimulation in women with poor ovarian response undergoing IVF: A randomized clinical trial

I. Bosdou, E. Kolymbianakis, X. Venetis, K. Dafopoulos, L. Zepiridis, K. Hatzimeletiou, A. Makedos, G. Anifantis, H. Messini, A. Danielidis, A. Mitsoli, D. Savvaidou, I. Messinis, V. Tarlatzis

HJOG, Volume 15, Supplement 1, May 2015.

 

12. Determination of the optimal dosage of triptorelin for the induction of terminal oocyte maturation in patients at high risk for Ovarian Hyperstimulation Syndrome (OHSS): A randomized clinical trial 

G. Lainas, I. Bosdou, C. Venetis, I. Sfontouris, K. Hatzimeletiou, L. Zepiridis, A. Makedos, A. Danielidis, A. Mitsoli, T. Lainas, V. Tarlatzis, E. Kolymbianakis _cc781905-5cde -3194-bb3b-136bad5cf58d_ 

HJOG, Volume 15, Supplement 1, May 2015.

 

13. Vaginal infections in women undergoing IVF: A retrospective study

A. Makedos, E. Kolymbianakis, A. Kalpatsanidis, A. Mitsolis, A. Hatzimeletiou, L. Zepiridis, V. Tarlatzis

HJOG, Volume 15, Supplement 1, May 2015.

 

14. Laparoscopic treatment of patients with endometrial cancer: Analysis of 10 cases 

G. Pantos, D. Tsolakidis, A. Makedos, V. Tarlatzis

HJOG, Volume 15, Supplement 1, May 2015.

 

15. Timely removal of foreign bodies laparoscopically from previous operations is crucial for a successful outcome

G. Pantos, A. Makedos, D. Tsolakidis, E. Koltsidas, V. Tarlatzis

HJOG, Volume 15, Supplement 1, May 2015.

 

16. Secondary “blind” endometrial cavity with functional endometrium: Unclassifiable uterine dysplasia (U6/C0/V0 by ESGE) – Presentation of laparoscopic management

A. Makedos, G. Pantos, S. Masouridou, V. Tarlatzis

HJOG, Volume 15, Supplement 1, May 2015.

bottom of page